|Articles|May 1, 2003

Excision Decision

Maui, Hawaii - Recent technological advances and findings from clinical studies can be put to use immediately to assure optimal diagnosis and management of malignant melanoma, Timothy S. Brown, M.D., said at the annual Hawaii Dermatology Seminar, sponsored by the Skin Disease Education Foundation.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Adaptive Learning

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Corey Cutler, MD, MPH, FRCP(C); Amin M. Alousi, MD; Mehdi Hamadani, MD; Anna Sureda, MD, PhD

Excision Decision

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Trending on Dermatology Times

FDA Accepts sBLA for OnabotulinumtoxinA in Masseter Muscle, Pursuing Fifth Aesthetic Indication

Zasocitinib Shows High Rates of Scalp Psoriasis Clearance Through Week 24

From Wound Care to Aesthetics: How Conexeu Plans to Capitalize on the Bio-Regeneration Market

HS Case Study: Recognizing Moderate Disease in an Adolescent

AAD Pediatric AD Guidelines Back Roflumilast, Ruxolitinib, Tapinarof